Programs that offer HIV tests which are used to identify individuals who have been infected with the Human Immunodeficiency Virus (HIV) and are at risk for developing AIDS (acquired immune deficiency syndrome) or which are used to measure progression of the disease in people known to be infected. The most common HIV screening test is the enzyme immunoassay (EIA) which most frequently uses peripheral blood drawn from the arm or a finger as a sample, but can also be conducted using serum, oral fluids or urine. Repeatedly reactive EIA tests are confirmed using the Western blot or the immunofluorescence assay (IFA). The most common test that is used to measure disease progression is the PCR (polymeraise chain reaction) or viral load test. Many programs that provide HIV testing also provide pre-testing and post-test counselling which includes information about AIDS/HIV, reducing risks for HIV transmission, emotional support to help the individual deal with the testing process and test results, and information about and referral to other AIDS-related services.
Programs that provide counselling services for individuals at risk for contracting or transmitting the HIV virus with the objective of supporting their ability to make behaviour changes that will reduce their risk of acquiring or transmitting HIV. Counselling involves a personal risk assessment, development of a personalized action plan and the decision to seek an HIV test. Individuals who have a history of injection drug use, sex with a person with HIV/AIDS, sex with a man who has sex with other men, sex with an injection drug user, a sexually transmitted disease, or exchanging money or drugs for sex are considered to be at high or increased risk and are targets for prevention counselling.
Programs that distribute condoms, lubricants, dental dams, bleach kits (ammonia or bleach for cleaning needles and instruction for use) and/or other supplies that can be used to help stop the spread of AIDS, other blood borne infectious diseases and sexually transmitted diseases among high-risk populations. Individuals who have a history of injection drug use, sex with a person with HIV/AIDS, sex with a man who has sex with other men, sex with an injection drug user, a sexually transmitted disease, or are exchanging money or drugs for sex are considered to be at high or increased risk.
Programs that provide treatment which includes approved medication (e.g., methadone, buprenorphine, naltrexone, antabuse) to support the efforts of individuals with an opioid or alcohol use disorder to abstain from or reduce their use of opioids (usually heroin or painkillers such as oxycontin or morphine) or alcohol. The extended-release, injectable form of naltrexone (Vivitrol) may also be used. The objective of maintenance is to gradually reduce the amount of the substitute drug that is required in order to reduce and, if possible, eventually eliminate dependency altogether. Medication assisted maintenance treatment (MAT) may be provided in an outpatient treatment program (OTP) or OTP unit such as a pharmacy or physician's office, or for buprenorphine products (Bunavail, Suboxone, Subutex, Zubslov), a physician's office or other health care setting. Methadone maintenance treatment is provided in a clinic. It is recommended that medication assisted maintenance treatment be provided in combination with counselling and behavioural therapies.
The above terms and definitions are part of the Taxonomy of Human Services, used here by permission of INFO LINE of Los Angeles.